BioLineRx Ltd. (Nasdaq: BLRX) announced that it has signed an exclusive, worldwide agreement with Yissum Research Development Company of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE